Pyxis Oncology Inc. (NASDAQ: PYXS) on Thursday released preliminary data from its ongoing Phase 1 studies of micvotabart pelidotin (MICVO) for recurrent/metastatic head and neck squamous cell ...

Pyxis secured S$13 million in the first close of its S$18 million growth funding round, reflecting strong investor confidence in its vessel technology, commercial traction, and regional growth ...

Jesse Calis spent a month with the Blackmagic PYXIS 12K cinema camera. His verdict: “If you are a serious filmmaker… this camera is really for you.” And how. Watch his full review of the Blackmagic ...

Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat solid tumors. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an ...

Beagle helps with cleaning chores in adorable way. Trump proposes new monument near Lincoln Memorial An American dream at risk: What happens to a small Nebraska town when 3,200 workers lose their jobs ...

Fishing duo Cole and Jay smoke the slabs in a runoff creek for catch and cook. GOP members face backlash after defying Trump Winter weather warning as 40 inches of snow to hit—travel "impossible" ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By James Austin and Ellen Airhart The best way to clean tile and grout in your ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Michael Sullivan Michael Sullivan is a writer covering kitchen equipment and ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician ...

US stocks tipped higher on Tuesday, with the S&P 500 clinching a fresh record, as Wall Street shrugged off fresh data that showed surprisingly strong growth in the US economy over the summer that led ...

46% confirmed objective response rate (ORR) and 92% disease control rate (DCR) observed with MICVO as monotherapy in 2L+ R/M HNSCC at 5.4 mg/kg 71% confirmed ORR and 100% DCR observed with MICVO in ...